180 related articles for article (PubMed ID: 37703536)
21. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
Chai Y; Ma Y; Feng W; Lu H; Jin L
World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
[TBL] [Abstract][Full Text] [Related]
22. Construction and Validation of a Novel Nomogram to Predict the Overall Survival of Patients With Combined Small Cell Lung Cancer: A Surveillance, Epidemiology, and End Results Population-Based Study.
Jiang A; Liu N; Zhao R; Liu S; Gao H; Wang J; Zheng X; Ren M; Fu X; Liang X; Tian T; Ruan Z; Yao Y
Cancer Control; 2021; 28():10732748211051228. PubMed ID: 34632799
[TBL] [Abstract][Full Text] [Related]
23. Is adjuvant chemotherapy for completely resected p-stage IA (>2 cm) and stage IB non-small-cell lung cancer beneficial for elderly patients? A large, retrospective cohort study based on real-world data from Japan.
Adachi H; Saito A; Shintani Y; Okami J; Ito H; Ohtsuka T; Mori T; Watanabe SI; Chida M; Endo S; Nakanishi R; Kadokura M; Suzuki H; Miyaoka E; Yoshino I; Date H; Japanese Joint Committee Of Lung Cancer Registry
Jpn J Clin Oncol; 2023 Dec; 53(12):1191-1200. PubMed ID: 37626449
[TBL] [Abstract][Full Text] [Related]
24. Risk stratification and adjuvant chemotherapy after radical resection based on the clinical risk scores of patients with stage IB-IIA non-small cell lung cancer.
Zhai W; Duan F; Li D; Yan Q; Dai S; Zhang B; Wang J
Eur J Surg Oncol; 2022 Apr; 48(4):752-760. PubMed ID: 34620508
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
Strauss GM; Herndon JE; Maddaus MA; Johnstone DW; Johnson EA; Harpole DH; Gillenwater HH; Watson DM; Sugarbaker DJ; Schilsky RL; Vokes EE; Green MR
J Clin Oncol; 2008 Nov; 26(31):5043-51. PubMed ID: 18809614
[TBL] [Abstract][Full Text] [Related]
26. The nomogram for the prediction of overall survival after surgery in patients in early-stage NSCLC based on SEER database and external validation cohort.
Zhang H; Zeng J; Li X; Zhang B; Wang H; Tang Q; Zhang Y; Bao S; Zu L; Xu X; Xu S; Song Z
Cancer Med; 2024 Jan; 13(1):e6751. PubMed ID: 38148585
[TBL] [Abstract][Full Text] [Related]
27. Treatment Patterns and Health Resource Utilization Among Patients Diagnosed With Early Stage Resected Non-Small Cell Lung Cancer at US Community Oncology Practices.
Buck PO; Saverno KR; Miller PJ; Arondekar B; Walker MS
Clin Lung Cancer; 2015 Nov; 16(6):486-95. PubMed ID: 25681298
[TBL] [Abstract][Full Text] [Related]
28. [Effect of Adjuvant Chemotherapy on DFS for Patients with Stage I NSCLC].
Peng S; Li X; Wang Y; Liu J
Zhongguo Fei Ai Za Zhi; 2017 Jul; 20(7):485-489. PubMed ID: 28738965
[TBL] [Abstract][Full Text] [Related]
29. Referral patterns for adjuvant chemotherapy in patients with completely resected non-small cell lung cancer.
Kassam F; Shepherd FA; Johnston M; Visbal A; Feld R; Darling G; Keshavjee S; Pierre A; Waddell T; Leighl NB
J Thorac Oncol; 2007 Jan; 2(1):39-43. PubMed ID: 17410008
[TBL] [Abstract][Full Text] [Related]
30. CT-based radiomics for predicting brain metastases as the first failure in patients with curatively resected locally advanced non-small cell lung cancer.
Sun F; Chen Y; Chen X; Sun X; Xing L
Eur J Radiol; 2021 Jan; 134():109411. PubMed ID: 33246270
[TBL] [Abstract][Full Text] [Related]
31. A Population-Based Study on the Prognostic factors and Efficacy of Adjuvant Chemotherapy in the Postoperative Stage for Patients with Stage IIA Non-Small Cell Lung Cancer.
Wang W; Teng F; Bu S; Xu W; Cai QC; Jiang YQ; Wang ZQ
Risk Manag Healthc Policy; 2022; 15():1581-1592. PubMed ID: 36046766
[TBL] [Abstract][Full Text] [Related]
32. Meta-analysis of the efficacy of postoperative adjuvant chemotherapy for stage IB non-small cell lung cancer.
Liu S; Wan S; Feng J; Pang Y; Wang H; Zeng H; Xu X
Medicine (Baltimore); 2024 Jan; 103(1):e36839. PubMed ID: 38181235
[TBL] [Abstract][Full Text] [Related]
33. A risk classification system predicting the cancer-specific survival for postoperative stage IB non-small-cell lung cancer patients without lymphovascular and visceral pleural invasion.
Tu Z; Li C; Tian T; Chen Q
Lung Cancer; 2021 Nov; 161():114-121. PubMed ID: 34583219
[TBL] [Abstract][Full Text] [Related]
34. [Current status of postoperative adjuvant chemotherapy for completely resected non-small lung cancer].
Tsuboi M
Nihon Geka Gakkai Zasshi; 2014 May; 115(3):125-9. PubMed ID: 24946518
[TBL] [Abstract][Full Text] [Related]
35. Survival benefit of resection surgery for lung adenocarcinoma with bone metastases and a post-operative prognosis nomogram establishment and validation.
Zhao H; Li W; Li X; Ding Z; Zhao S
J Thorac Dis; 2022 Dec; 14(12):4877-4893. PubMed ID: 36647503
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of a nomogram model for cancer-specific survival of patients with poorly differentiated thyroid carcinoma: A SEER database analysis.
Jin S; Liu H; Yang J; Zhou J; Peng D; Liu X; Zhang H; Zeng Z; Ye YN
Front Endocrinol (Lausanne); 2022; 13():882279. PubMed ID: 36176465
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of a nomogram to predict postoperative cancer-specific survival of patients with nonmetastatic T3a renal cell carcinoma.
Guo P; Wang Y; Han Y; Wei D; Zhao J; Li M; Jiang Y; Luo Y
Urol Oncol; 2021 Dec; 39(12):835.e19-835.e27. PubMed ID: 34620554
[TBL] [Abstract][Full Text] [Related]
38. A clinical variable-based nomogram could predict the survival for advanced NSCLC patients receiving second-line atezolizumab.
Shang X; Shi J; Wang X; Zhao C; Yu H; Wang H
Cancer Med; 2021 Sep; 10(18):6218-6226. PubMed ID: 34331414
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant chemotherapy for elderly patients with non-small-cell lung cancer.
Yamanashi K; Okumura N; Yamamoto Y; Takahashi A; Nakashima T; Matsuoka T; Kameyama K
Asian Cardiovasc Thorac Ann; 2017 Jun; 25(5):371-377. PubMed ID: 28592139
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of nomogram prognostic model for early-stage T1-2N0M0 small cell lung cancer: A population-based analysis.
Ge T; Zhu S; Sun L; Yin L; Dai J; Qian J; Chen X; Zhang P; Zhu J; Jiang G
Front Oncol; 2022; 12():921365. PubMed ID: 36465408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]